0QOK.LSE Roche Holding AG Participation

Healthcare Commercial Services & Supplies London Exchange
- GBP
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.

Is 0QOK.LSE undervalued?

Graham number

The Graham number of Roche Holding AG Participation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Roche Holding AG Participation fundamental analysis

No fundamental analysis for Roche Holding AG Participation yet.

Roche Holding AG Participation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Roche Holding AG Participation

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various dise…

Full company profile